PM Group chief executive David Murphy said the pharma sector accounted for two-thirds of overall revenues generated last year.

PM Group, the Irish-based international engineering and construction management company, saw its operating profit jump 30 per cent last year to €34.8 (...)

Wall Street’s three major indices were higher in early afternoon trading as improving economic data and the prospect of more stimulus bolstered hopes of a swift recovery from Covid. Photograph: Michael Nagle/Bloomberg

European shares rose to their highest level in two weeks on Tuesday, with banks among the main gainers in Dublin, as investors piled into stocks that (...)

None of the grounds put forward by Teva was accepted by the High Court and the judge therefore declined to grant the order sought. Photograph: iStock

An Irish pharmaceutical company has failed to get a High Court order revoking a patent for an invention related to an inhalation capsule used in the t(...)

The sale arose as part of a requirement from the European Commission to sell off certain assets from an earlier deal between Sanofi and German drugmaker Boehringer Ingelheim.   Photograph:  Reuters/Philippe Wojazer

Drugmaker Ipsen has agreed to buy five consumer healthcare products from bigger French rival Sanofi for €83 million, in a deal which Ipsen said shoul(...)

CRH, which has been upgraded by Goldman Sachs,  rose 1.05% to €25.93

Global equity markets rallied yesterday as oil prices moved away from multi-year lows, though investors remained mindful of the possibility for more v(...)

Norton (Waterford) Ltd, trading as Teva Pharmaceuticals Ireland, wants the court to order revocation of a patent issued to Boehringer Ingelheim International GMBH for its Spiriva Handihaler device.

Two drug companies are in dispute over the patent for an alleged invention related to an inhalation capsule used in the treatment of chronic obstructi(...)

The drug could cost women as much as $400 per month

Valeant Pharmaceuticals agreed to pay about $1 billion (€895 million) in cash for Sprout Pharmaceuticals, the US pharmaceutical group that this week r(...)

The drug flibanserin, which is marketed under the trade name Addyi, nicknamed “female Viagra”.

It has been dubbed the “female Viagra” and this week it became the first drug for treating loss of libido in women to win approval in the US. The deci(...)

The drug flibanserin, under the trade name Addyi, nicknamed “female Viagra” is shown in this undated Sprout Pharmaceuticals handout photograph released on Tuesday. Photograph: Sprout Pharmaceuticals/Reuters.

The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous l(...)

Esther and Stephen Hourigan: Esther will receive an award for saving Stephen’s life when he suffered a stroke at the age of 31.

Like most parents, Karen Le Blanc had never heard of childhood stroke until it hit her own family completely out of the blue when her three-year-old d(...)